Counter-Strike: your end vs Low Cortisol (BO3) - CCT South America Group Stage
Prezzo e movimenti rilevanti
Movimento 7 · perché il prezzo si è mosso
5 nov, 23:08 UTC → 23:38
Cosa è successo e perché
No fact in the dossier explains the rise in the YES price in the late-evening window on November 5. The only item tied to this match is a listing page published earlier that day, which confirms the November 6 date and so predates the move [90]. A separate listing shows Low Cortisol had another match two days earlier [91], but it gives no result or other information that could have triggered a repricing. The cause of the move is therefore not evident from the available facts.
Fonti
Perché sì
Avvocato «sì»The match was publicly listed for November 6 by the morning of November 5, hours before the late-evening price move. The move therefore does not look like a reaction to a schedule announcement. That fits a correction of an earlier, stale quote more than a speculative overshoot, and the dossier gives no sign that the repricing has gone too far.
The market had been open for many hours before the jump, which leaves room for the earlier low quote to reflect thin trading rather than a considered assessment of the matchup. If so, the move toward a near-even price is the market catching up, and the underdog side may still be underpriced.
Low Cortisol played a separate BO3 against BORRACHEIROS on November 4, two days before facing your end. A compressed group-stage schedule can mean less preparation time and more exposure of their tactics. These are modest factors, but they favor the side with the lower rating.
Nothing in the dossier establishes Low Cortisol as a clear favorite. It contains no results, rosters or form data that would justify the earlier lopsided price. Without evidence of a large gap, a BO3 between two teams in a regional group stage leaves real room for the less-favored side.
The opposing side is right that the dossier has no explicit catalyst for the late move, but that cuts both ways. Nothing in the dossier shows the earlier, lower price rested on stronger evidence either. The only match-specific item is a listing page confirming the fixture for November 6 (id 90), and it was published before the move. It says nothing about roster, form or head-to-head, so it gives no support for treating the earlier price as the better-informed one. The absence of a visible trigger does not show that the repricing was mistaken. · replica
The argument built on the BORRACHEIROS fixture reads more into it than the dossier allows. The listing only shows that Low Cortisol had a separate match two days earlier (id 91). It gives no result, no performance data and nothing on the opponent's strength. It therefore cannot show that Low Cortisol is stronger than the earlier price implied, and it cannot be used to argue that the move toward a near-even price is unsupported. The dossier is thin for both sides, which fits with a market that has become more balanced about this fixture. · replica
Perché no
Avvocato «no»The price jump late on November 5 has no catalyst in the dossier. The only item about this match is a listing page published earlier that day, which only confirms the November 6 schedule. A scheduling confirmation that predates the move does not explain it, so the move may overstate what is actually known.
The listing page names the fixture 'Low Cortisol vs. your end' and gives only its date. It contains no roster changes, form data or head-to-head information that would justify moving the market from a clear lean toward Low Cortisol to a near-even price. A sharp repricing without supporting evidence is more consistent with a short-term swing than with new fundamentals.
Low Cortisol was already scheduled for a match against BORRACHEIROS on November 4, two days before this one. That shows the team is an active participant in the group-stage calendar with recent match rhythm. The dossier does not give the result, but it offers nothing suggesting Low Cortisol is weaker than the earlier pricing implied.
The dossier has no information on 'your end' that would support the late rise, such as recent results or lineup news. With only schedule listings available, the late move toward a coin-flip price looks stronger than the evidence supports, which argues for caution about the current YES price.
The opposing case treats the move as a correction of a stale quote, but the dossier does not support that reading. It shows only that the match was listed for November 6 earlier on November 5 [90]. That fact explains why the market existed. It says nothing about why the price rose in a short window late in the evening. Since the listing was already public, the dossier gives no new information that would justify calling the earlier price stale or the new one more accurate. The claim that the repricing has not gone too far is an assumption, not something the dossier establishes. · replica
The scheduling argument is weak. The dossier shows only that Low Cortisol had a separate match against BORRACHEIROS on November 4, two days before this one [91]. A two-day gap is not evidence of fatigue, compressed preparation or exposed tactics, and the dossier contains no results, roster or form information tied to that match. Using it to favor the lower-rated side goes beyond the facts. The opposing case also admits the dossier has no data on team strength, so it cannot show that the earlier price was wrong or that the newer, higher one is justified. · replica